Amylin Pharmaceuticals To Shut San Diego Operations
socalTECH
APRIL 5, 2013
However, it looks like the acquisition of San Diego''s Amylin Pharmaceuticals by Bristol-Myers Squibb is turning out not-so-great for employees in the location, after news that Bristol-Myers Squibb plans to close its San Diego operations , resulting in the loss of hundreds of jobs. READ MORE>>.
Let's personalize your content